Principal Investigator
Oriana Damas
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20221350
Clinical Trial Summary
IM047029-A Phase 4, Prospective, Open-label Study of Ozanimod to Explore the Safety, Efficacy, Quality of Life, and Biomarker Response in Participants with Moderate to Severe Ulcerative Colitis in Clinical Practice
Phase
TBD
Funding Agency/Sponsor
Industry
Disease
Gastrointestinal, Stomach, Esophageal
Contact Information
Study Contact
Niurka Colina
Phone Number
+1 (305) 2436405
Email
nxc610@miami.edu